Acology Inc. Announces Year End Update

CORONA, CA--(Marketwired - December 16, 2015) - Acology Inc. (OTC PINK: ACOL) announced today year-to-date unit sales for its signature product, the MedTainer™, have increased 270% from the same period last year. Unit sales are well over 300,000 for the first time in the company's history. Order totals have topped 5,600, an increase of over 400% in the past twelve months. Management also states that internet sales will top the 4,000 mark. Acology confidently projects gross sales for calendar 2016 will exceed $3.75M, a 250% increase over calendar 2015. In addition, new products that will concentrate on the MMJ and RMJ markets will come online in 2016, diversifying Acology's business offerings and increasing market share.

At the beginning of September 2015 Acology found itself in the unique position of having a single, stand-alone product serving two distinct markets. The projected adoption of Medical and Recreational Marijuana laws in as many as 16 additional states, and regulations for compliant packaging to meet the consumer demand driven by legalization, puts Acology and The Medtainer into a unique position to exploit that demand.

In addition Acology sales executives have begun to sell The MedTainer to open the geriatric, hospice and palliative care industries and have added 3 distinguished professionals in that field to its Advisory Board. These included 2 of the most well-known executives in the administration of Hospitals, Skilled Nursing Facilities and transitional home-care and one of the premiere geriatricians in the United States. In concert they have introduced Acology to the rapidly-growing medical equipment and skilled-nursing fields. The MedTainer, with its unique capability to grind pills in seconds, is increasingly being used by care givers for their patients who choose to have their convalescence in-home rather than a hospital setting.

Acology approaches the close of calendar 2015 with the certain knowledge that demand for their signature product, The MedTainer, will continue to increase domestically and globally. The original 45 distributors that Acology held in October of 2014 has grown to over 950 domestic and international distributors, wholesalers, merchants and brokers. The original physical 5200 sq.ft. sales and distribution center in Corona is expanding an additional 5,000 sq. ft. by the beginning of 2016. New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases.

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 201 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's email is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649)